Table 3 Time to recovery and all-cause mortality by oxygen delivery mode and baseline imputed PaO2/FiO2 at baseline
Oxygen delivery at baseline | ||||
|---|---|---|---|---|
HFNC | ||||
Placebo (n = 82) | Auxora (n = 81) | Difference (95% CI) | P value | |
Median time to recovery, days (95% CI) | 17.0 (8.0, 30.0) | 9.0 (7.0, 13.0) | 0.1079 | |
All-Cause Mortality at Day 60, n (%) | 21 (25.6%) | 13 (16.0%) | −9.36 (−21.79, 3.07) | 0.1436 |
Low flow oxygen | ||||
|---|---|---|---|---|
Placebo (n = 49) | Auxora (n = 49) | Difference (95% CI) | P value | |
Median time to recovery, days (95% CI) | 7.0 (5.0, 9.0) | 5.0 (4.0, 6.0) | 0.4195 | |
All-Cause Mortality at Day 60, n (%) | 6 (12.2%) | 5 (10.2%) | −2.04 (−14.53, 10.45) | 0.7490 |
Baseline imputed PaO2/FiO2 at baseline | ||||
|---|---|---|---|---|
≤ 100 | ||||
Placebo (n = 58) | Auxora (n = 59) | Difference (95% CI) | P value | |
Median time to recovery, days (95% CI) | 23.0 (11.0, 70.0) | 11.5 (8.0, 23.0) | 0.1040 | |
All-Cause Mortality at Day 60, n (%) | 17 (29.3%) | 12 (20.3%) | −8.62 (−24.30, 7.06) | 0.2837 |
101–200 | ||||
|---|---|---|---|---|
Placebo (n = 73) | Auxora (n = 71) | Difference (95% CI) | P Value | |
Median time to recovery, days (95% CI) | 7.0 (5.0, 8.0) | 6.0 (5.0, 7.0) | 0.4156 | |
All-Cause Mortality at Day 60, n (%) | 10 (13.7%) | 6 (8.5%) | −5.25 (−15.45, 4.95) | 0.3164 |